{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:53:40Z","timestamp":1782978820033,"version":"3.54.5"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To compare levetiracetam and phenytoin as prophylaxis for the short-term development of status epilepticus (SE) during care of pediatric patients with acute severe traumatic brain injury (TBI).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Nonprespecified secondary analysis using propensity score matching.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>We used the Approaches and Decisions in Acute Pediatric TBI Trial (ADAPT NCT04077411) dataset (2014\u20132017).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SUBJECTS:<\/jats:title>\n            <jats:p>Patients less than 18 years old with Glasgow Coma Scale Score less than or equal to 8 who received levetiracetam or phenytoin as a prophylactic anticonvulsant therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTION:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENT AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Of the 516 total patients who qualified for the case-control study, 372 (72.1%) patients received levetiracetam, and 144 (27.9%) received phenytoin. After propensity score matching, the pair-matched analysis with 133 in each group failed to identify an association between levetiracetam versus phenytoin use and occurrent of SE (3.8% vs. 0.8%, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.22), or mortality (i.e., in-hospital, 30-d and 60-d). However, on closer inspection of the statistical testing, we cannot exclude the possibility that selecting levetiracetam rather than phenytoin for prophylaxis was associated with the following: up to a mean difference of 7.3% greater prevalence of SE; up to a mean difference of 13.9%, 12.1%, and 13.9% greater mortality during the hospital stay, and 30-, and 60-days after hospital arrival, respectively. Last, analysis of 6 months Glasgow Outcome Scale Extended score in those without premorbid comorbidities, there was an association between favorable outcomes and use of phenytoin rather than levetiracetam prophylaxis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In ADAPT, the decision to use prophylactic levetiracetam versus phenytoin failed to show an association with occurrence of subsequent SE, or mortality. However, we are unable to exclude the possibility that selecting levetiracetam rather than phenytoin for prophylaxis was associated with greater prevalence of SE and mortality. We are unable to make any recommendation about one prophylactic anticonvulsant medication over the other, but recommend that further larger, contemporary studies in severe pediatric TBI are carried out.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003526","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T14:01:18Z","timestamp":1715176878000},"page":"710-719","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Levetiracetam or Phenytoin as Prophylaxis for Status Epilepticus: Secondary Analysis of the \u201cApproaches and Decisions in Acute Pediatric Traumatic Brain Injury Trial\u201d (ADAPT) Dataset, 2014\u20132017*"],"prefix":"10.1097","volume":"25","author":[{"given":"Nasim","family":"Ahmed","sequence":"first","affiliation":[{"name":"Department of Surgery, Hackensack Meridian School of Medicine, Nutley, NJ."},{"name":"Division of Trauma and Surgical Critical Care, Jersey Shore University Medical Center, Neptune, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Russo","sequence":"additional","affiliation":[{"name":"Division of Trauma, Jersey Shore University Medical Center, Neptune, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Hong","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ."},{"name":"Office of Research Administration, Hackensack Meridian Health Research Institute, Nutley, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/PCC.0000000000000948","article-title":"Seizures in children with severe traumatic brain injury.","volume":"18","author":"Bennett","year":"2017","journal-title":"Pediatr Crit Care Med"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"e220891","DOI":"10.1001\/jamanetworkopen.2022.0891","article-title":"Comparison of intracranial pressure measurements before and after hypertonic saline or mannitol treatment in children with severe traumatic brain injury.","volume":"5","author":"Kochanek","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"e2220969","DOI":"10.1001\/jamanetworkopen.2022.20969","article-title":"Comparative effectiveness of diversion of cerebrospinal fluid for children with severe traumatic brain injury.","volume":"5","author":"Bell","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"e1393","DOI":"10.1212\/WNL.0000000000200912","article-title":"Mortality, disability, and prognostic factors of status epilepticus: A nationwide population-based retrospective cohort study.","volume":"99","author":"Choi","year":"2022","journal-title":"Neurology"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/neuros\/nyz051","article-title":"Guidelines for the management of pediatric severe traumatic brain injury, third edition: Update of the brain trauma foundation guidelines, executive summary.","volume":"84","author":"Kochanek","year":"2019","journal-title":"Neurosurgery"},{"key":"R7-20250502","first-page":"e14956","article-title":"A comparison of seizure prophylaxis: Phenytoin versus levetiracetam.","volume":"13","author":"Fiani","year":"2021","journal-title":"Cureus"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/PCC.0000000000002576","article-title":"Early use of antiseizure medication in mechanically ventilated traumatic brain injury cases: A retrospective Pediatric Health Information System Database study.","volume":"22","author":"Haque","year":"2021","journal-title":"Pediatr Crit Care Med"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: Nonparametric preprocessing for parametric causal inference.","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJM199008233230801","article-title":"A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures.","volume":"323","author":"Temkin","year":"1990","journal-title":"N Engl J Med"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1528-1167.2008.02005.x","article-title":"Preventing and treating posttraumatic seizures: The human experience.","volume":"50","author":"Temkin","year":"2009","journal-title":"Epilepsia"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.annemergmed.2003.09.016","article-title":"A randomized, double-blinded, placebo-controlled trial of phenytoin for the prevention of early posttraumatic seizures in children with moderate to severe blunt head injury.","volume":"43","author":"Young","year":"2004","journal-title":"Ann Emerg Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1111\/epi.12326","article-title":"Results of phase II levetiracetam trial following acute head injury in children at risk for posttraumatic epilepsy.","volume":"54","author":"Pearl","year":"2013","journal-title":"Epilepsia"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0140-6736(19)30722-6","article-title":"Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): An open-label, multicentre, randomised controlled trial.","volume":"393","author":"Dalziel","year":"2019","journal-title":"Lancet"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(19)30724-X","article-title":"Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): A multicentre, open-label, randomised trial.","volume":"393","author":"Lyttle","year":"2019","journal-title":"Lancet"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1212\/01.wnl.0000243197.05519.3d","article-title":"Practice parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.","volume":"67","author":"Riviello","year":"2006","journal-title":"Neurology"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003526","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:35:56Z","timestamp":1746207356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003526","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,8]]}}}